Accelerating Evidence to Action in Pharma with Practical AI Adoption - with Nabil Khan of Pfizer

AI in Business by Daniel Faggella

Pharma organizations are generating more clinical and scientific evidence than ever, yet the path from that evidence to a confident strategic call hasn't kept up. In this episode, Nabil Khan, Medical Director for Interna...View more